Search Results for keywords:"21 U.S.C. 952(a)(2)"

Found 23 results

Search Results: keywords:"21 U.S.C. 952(a)(2)"

💰 Only
Oldest Newest
  • 2021-03919 — Importer of Controlled Substances Application: Myonex Inc
    Type:Notice
    Citation:86 FR 11558
    Reading Time:about a minute or two

    Myonex Inc has applied for registration as an importer of specific controlled substances, according to a notice from the Drug Enforcement Administration (DEA). The substances are intended for use in clinical trials, research, and analytical purposes, and not for commercial sale of finished dosage forms. Interested parties have until March 29, 2021, to submit written comments or objections, or to request a hearing regarding this application. Written submissions should be directed to the DEA at their office in Springfield, Virginia.

    Simple Explanation

    Myonex Inc wants to bring in some special medicines from other countries to use in experiments and tests but not to sell them in stores. If anyone has questions or concerns, they can tell the people in charge by March 29, 2021.

  • 2021-04147 — Importer of Controlled Substances Application: Microgenics Corporation Thermo Fisher Scientific
    Type:Notice
    Citation:86 FR 12033
    Reading Time:about a minute or two

    Microgenics Corporation, a part of Thermo Fisher Scientific, has applied to the Drug Enforcement Administration (DEA) to become a registered importer of certain controlled substances. These substances are intended for use in feasibility and cross-reactivity studies related to diagnostic products. Comments and objections regarding this application, as well as requests for a hearing, must be submitted to the DEA by March 31, 2021. The DEA will only approve the permit if the company’s activities align with specific legal requirements under U.S. law.

    Simple Explanation

    Microgenics Corporation, part of a big science company, wants permission from the government to bring special chemicals into the country to help make better health tests. Before they can get the okay, people can share their thoughts until the end of March, and the company must promise to follow the rules so nothing bad happens.

  • 2025-03061 — Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC
    Type:Notice
    Citation:90 FR 10731
    Reading Time:about a minute or two

    Catalent Pharma Solutions, LLC has applied to the Drug Enforcement Administration (DEA) to be registered as an importer of certain controlled substances. The company plans to import these substances in finished dosage forms for clinical trials, research, and analytical activities. Comments or objections regarding this application can be submitted electronically by March 28, 2025. Any hearing requests should be sent to the DEA at their Springfield, Virginia address.

    Simple Explanation

    Catalent Pharma Solutions wants to bring certain special medicines from other countries into the U.S. so they can use them for important tests and studies. People have until March 28, 2025, to say if they have any concerns about this.

Previous